Final overall survival analysis for the phase II RECORD-3 study of first-line everolimus followed by sunitinib versus first-line sunitinib followed by everolimus in metastatic RCC

Những quyển sách tương tự

• Final overall survival analysis for the phase II RECORD-3 study of first-line everolimus followed by sunitinib versus first-line sunitinib followed by everolimus in metastatic RCC
  Bằng: Knox, J J, et al.
  Được phát hành: (2018)
• Phase II Randomized Trial Comparing Sequential First-Line Everolimus and Second-Line Sunitinib Versus First-Line Sunitinib and Second-Line Everolimus in Patients With Metastatic Renal Cell Carcinoma
  Bằng: Motzer, Robert J., et al.
  Được phát hành: (2014)
• Genomic Biomarkers of a Randomized Trial Comparing First-line Everolimus and Sunitinib in Patients with Metastatic Renal Cell Carcinoma
  Bằng: Hsieh, James J., et al.
  Được phát hành: (2016)
• A single arm phase 1b study of everolimus and sunitinib in patients with advanced renal cell carcinoma (RCC)
  Bằng: Kanesvaran, R., et al.
  Được phát hành: (2014)
• Survival Benefits of Second-line Axitinib Versus Everolimus After First Line Sunitinib Treatment in Metastatic Renal Cell Carcinoma
  Bằng: Géczi, Lajos, et al.
  Được phát hành: (2020)